Schroder Investment Management Group Reduces Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Schroder Investment Management Group lessened its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 405,847 shares of the company's stock after selling 25,031 shares during the quarter. Schroder Investment Management Group owned approximately 2.69% of U.S. Physical Therapy worth $36,218,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. CBIZ Investment Advisory Services LLC raised its position in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after acquiring an additional 122 shares in the last quarter. Venturi Wealth Management LLC grew its stake in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares during the period. Pacer Advisors Inc. bought a new stake in U.S. Physical Therapy in the fourth quarter worth approximately $113,000. Mutual of America Capital Management LLC acquired a new position in U.S. Physical Therapy in the fourth quarter valued at approximately $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock worth $223,000 after buying an additional 956 shares in the last quarter.

U.S. Physical Therapy Stock Down 2.7 %

Shares of USPH traded down $1.83 on Friday, reaching $66.96. The company's stock had a trading volume of 148,968 shares, compared to its average volume of 103,811. U.S. Physical Therapy, Inc. has a twelve month low of $65.59 and a twelve month high of $108.91. The stock has a market capitalization of $1.02 billion, a PE ratio of 71.23, a PEG ratio of 3.54 and a beta of 1.37. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a fifty day moving average of $81.32 and a 200-day moving average of $86.12.

Remove Ads

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. Equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a $0.45 dividend. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date is Friday, March 14th. This represents a $1.80 annualized dividend and a dividend yield of 2.69%. U.S. Physical Therapy's dividend payout ratio is presently 97.83%.

Insider Activity

In other news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. StockNews.com lowered shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. decreased their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. Barrington Research cut their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. Finally, William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.